XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ 3,754 $ (1,136)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 1,721 1,678
Share based compensation (8,204) 1,760
Deferred income taxes (26) (627)
Bad debt expense 142 19
(Increase) decrease in operating assets and increase (decrease) in operating liabilities:    
Accounts receivable 880 (46)
Inventories - finished goods 3,036 (10,185)
Prepaid income taxes 188 335
Prepaid expenses and other current assets 2,474 (2,390)
Operating lease right-of-use assets, net 135 196
Accounts payable (12,558) 9,115
Sales tax payable 319 500
Accrued expenses and other current liabilities (505) 1,295
Lease liabilities (133) (205)
Deferred revenue (457) 253
Income taxes payable 717 0
Net cash (used in) provided by operating activities (8,517) 562
Cash flows from investing activities:    
Acquisition of PetCareRx, net of cash acquired 0 (35,859)
Purchases of property and equipment (683) (1,153)
Net cash used in investing activities (683) (37,012)
Cash flows from financing activities:    
Dividends paid (104) (6,102)
Net cash used in financing activities (104) (6,102)
Net decrease in cash and cash equivalents (9,304) (42,552)
Cash and cash equivalents, at beginning of period 55,296 104,086
Cash and cash equivalents, at end of period 45,992 61,534
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 81 0
Dividends payable in accrued expenses and other current liabilities $ 112 $ 1,507